Alpha 2.0
Login Register
» Authors » Shravan Kethireddy

Shravan Kethireddy

Explore the profile of Shravan Kethireddy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 546
Followers 0
Related Specialties
Critical Care
Emergency Medicine
General Medicine
Top 10 Co-Authors
Anand Kumar
Uchenna R Ofoma
Aseem Kumar
Jonathan H Chow
Michael A Mazzeffi
Joseph E Parrillo
Yazdan Mirzanejad
H Lester Kirchner
Amanda Sees
Paul Griffin
Published In
Crit Care Med
J Intensive Care Med
BMJ Open
Expert Opin Drug Metab Toxicol
Crit Care
Affiliations
Soon will be listed here.
Recent Articles
1.
Novel Machine Learning Identifies 5 Asthma Phenotypes Using Cluster Analysis of Real-World Data
Wu C, Sleiman J, Fakhry B, Chedraoui C, Attaway A, Bhattacharyya A, et al.
J Allergy Clin Immunol Pract . 2024 Apr; 12(8):2084-2091.e4. PMID: 38685479
Background: Asthma classification into different subphenotypes is important to guide personalized therapy and improve outcomes. Objectives: To further explore asthma heterogeneity through determination of multiple patient groups by using novel...
2.
Forecasting disease trajectories in critical illness: comparison of probabilistic dynamic systems to static models to predict patient status in the intensive care unit
Duggal A, Scheraga R, Sacha G, Wang X, Huang S, Krishnan S, et al.
BMJ Open . 2024 Feb; 14(2):e079243. PMID: 38320842
Objective: Conventional prediction models fail to integrate the constantly evolving nature of critical illness. Alternative modelling approaches to study dynamic changes in critical illness progression are needed. We compare static...
3.
Trajectory of PaO/FiO Ratio in Shock After Angiotensin II
Wieruszewski P, Coleman P, Levine A, Davison D, Smischney N, Kethireddy S, et al.
J Intensive Care Med . 2023 May; 38(10):939-948. PMID: 37161301
Introduction: High-dose catecholamines can impair hypoxic pulmonary vasoconstriction and increase shunt fraction. We aimed to determine if Angiotensin II (Ang-2) is associated with improved PaO/FiO and SpO/FiO in patients in...
4.
Structural causal model with expert augmented knowledge to estimate the effect of oxygen therapy on mortality in the ICU
Gani M, Kethireddy S, Adib R, Hasan U, Griffin P, Adibuzzaman M
Artif Intell Med . 2023 Mar; 137:102493. PMID: 36868692
Recent advances in causal inference techniques, more specifically, in the theory of structural causal models, provide the framework for identifying causal effects from observational data in cases where the causal...
5.
Integrated Digital Health System Tools to Support Decision Making and Treatment Preparation in CKD: The PREPARE NOW Study
Green J, Ephraim P, Hill-Briggs F, Browne T, Strigo T, Hauer C, et al.
Kidney Med . 2021 Aug; 3(4):565-575.e1. PMID: 34401724
Rationale & Objective: Digital health system tools to support shared decision making and preparation for kidney replacement treatments for patients with chronic kidney disease (CKD) are needed. Study Design: Descriptive...
6.
A boosting inspired personalized threshold method for sepsis screening
Feng C, Griffin P, Kethireddy S, Mei Y
J Appl Stat . 2021 Jun; 48(1):154-175. PMID: 34113056
Sepsis is one of the biggest risks to patient safety, with a natural mortality rate between 25% and 50%. It is difficult to diagnose, and no validated standard for diagnosis...
7.
Early Detection of Septic Shock Onset Using Interpretable Machine Learners
Misra D, Avula V, Wolk D, Farag H, Li J, Mehta Y, et al.
J Clin Med . 2021 Jan; 10(2). PMID: 33467539
Background: Developing a decision support system based on advances in machine learning is one area for strategic innovation in healthcare. Predicting a patient's progression to septic shock is an active...
8.
A Multicenter Observational Cohort Study of Angiotensin II in Shock
Smith S, Newsome A, Guo Y, Hecht J, McCurdy M, Mazzeffi M, et al.
J Intensive Care Med . 2020 Nov; 37(1):75-82. PMID: 33231111
Introduction: Angiotensin II (Ang-2) is a non-catecholamine vasopressor that targets the renin-angiotensin-aldosterone system by agonism of the angiotensin type 1 receptor. Its utility as a vasopressor and a catecholamine-sparing agent...
9.
Predictors and outcomes of healthcare-associated infections in COVID-19 patients
Kumar G, Adams A, Hererra M, Rojas E, Singh V, Sakhuja A, et al.
Int J Infect Dis . 2020 Nov; 104:287-292. PMID: 33207271
Introduction: Healthcare-associated infections (HAI) after viral illnesses are important sources of morbidity and mortality. This has not been extensively studied in hospitalized COVID-19 patients. Methods: This study included all COVID-19-positive...
10.
Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019
Chow J, Khanna A, Kethireddy S, Yamane D, Levine A, Jackson A, et al.
Anesth Analg . 2020 Oct; 132(4):930-941. PMID: 33093359
Background: Coronavirus disease-2019 (COVID-19) is associated with hypercoagulability and increased thrombotic risk in critically ill patients. To our knowledge, no studies have evaluated whether aspirin use is associated with reduced...